Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bcl-2-like protein 15 (BCL2L15) is a member of the Bcl-2 protein family, known for their involvement in the regulation of apoptosis. This protein is predicted to localize primarily to the cytosol and nucleus in human cells. Its function is associated with the regulation of cell death pathways, although there is no evidence that it acts as a direct therapeutic target or has validated disease associations. BCL2L15 is primarily identified through gene expression studies, with RNA and protein detected in several tissues. Its role is mainly inferred from its sequence similarity to other Bcl-2 family proteins, with putative pro-apoptotic activity, but lacking direct functional or clinical validation[1][5][6][7].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bcl-2-like protein 15 (BCL2L15).